ResearchLong-term Safety, Efficacy, and PROs: Phase 3 Study of Leuprolide Acetate 6-month IM Depot in Central Precocious Puberty
ResearchOpen-Label 9-Year Follow-Up Extension Phase 2 Study of Once-Weekly Somatrogon in Children With Growth Hormone Deficiency
ResearchOnce-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study
ResearchConsensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH Research Society
ResearchDifferences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia
ResearchImpact of Growth Hormone on Skeletal Muscle Strength, Power, Endurance, and Agility in Prepubertal Boys With Short Stature
ResearchUnstimulated Luteinizing Hormone for Assessment of Suppression during Treatment of Central Precocious Puberty with 6-Month Subcutaneous Leuprolide Acetate: Correlations with Clinical Response
ResearchCost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents With Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial
ResearchManagement of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review
ResearchAn open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
ResearchUtility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study
ResearchThe Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic White and Minority Adults and Children With Type 1 Diabetes
ResearchEfficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study